Emily Burton Smith, PharmD, has extensive experience in the pharmaceutical industry, currently serving as the Director of Integrated Evidence Planning at Dexcom. Prior roles include Health Economics Outcomes Research Director at Zealand Pharma and Field Medical Director at Covis Pharma. Additionally, Emily held the position of Women's Health Executive Medical Science Liaison at AMAG Pharmaceuticals, focusing on key opinion leaders and payers on the West Coast, as well as Women's Health Medical Science Liaison for AbbVie in the Pacific Northwest and Northern California. Emily holds a PharmD from the University of California San Francisco - School of Pharmacy and a certification in Pharmacoeconomics from the University of Arizona Tucson.